192 related articles for article (PubMed ID: 30008173)
1. Targeting tumor necrosis factor receptors in ankylosing spondylitis.
Lata M; Hettinghouse AS; Liu CJ
Ann N Y Acad Sci; 2019 Apr; 1442(1):5-16. PubMed ID: 30008173
[TBL] [Abstract][Full Text] [Related]
2. TNF-alpha inhibitors for ankylosing spondylitis.
Maxwell LJ; Zochling J; Boonen A; Singh JA; Veras MM; Tanjong Ghogomu E; Benkhalti Jandu M; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2015 Apr; (4):CD005468. PubMed ID: 25887212
[TBL] [Abstract][Full Text] [Related]
3. Drug insight: anti-tumor-necrosis-factor therapy for ankylosing spondylitis.
Henderson C; Davis JC
Nat Clin Pract Rheumatol; 2006 Apr; 2(4):211-8. PubMed ID: 16932687
[TBL] [Abstract][Full Text] [Related]
4. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
[TBL] [Abstract][Full Text] [Related]
5. [Anti-TNF alpha in the treatment of rheumatoid arthritis and ankylosing spondylitis].
Lanfant-Weybel K; Lequerré T; Vittecoq O
Presse Med; 2009 May; 38(5):774-87. PubMed ID: 19327945
[TBL] [Abstract][Full Text] [Related]
6. Editorial review: how early should ankylosing spondylitis be treated with a tumor necrosis factor-blocker?
Haibel H; Sieper J
Curr Opin Rheumatol; 2010 Jul; 22(4):388-92. PubMed ID: 20473176
[TBL] [Abstract][Full Text] [Related]
7. Working life and physical activity in ankylosing spondylitis pre and post anti-tumor necrosis factor-alpha therapy.
Prince DS; McGuigan LE; McGirr EE
Int J Rheum Dis; 2014 Feb; 17(2):165-72. PubMed ID: 24576272
[TBL] [Abstract][Full Text] [Related]
8. Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis.
De Keyser F; Baeten D; Van den Bosch F; Kruithof E; Verbruggen G; Mielants H; Veys E
Drugs; 2004; 64(24):2793-811. PubMed ID: 15563249
[TBL] [Abstract][Full Text] [Related]
9. [Anti-TNF alfa therapy in ankylosing spondylitis].
Cravo AR; Tavares V; Da Silva JC
Acta Med Port; 2006; 19(2):141-50. PubMed ID: 17187716
[TBL] [Abstract][Full Text] [Related]
10. Tumour necrosis factor inhibitors in ankylosing spondylitis.
Reed MR; Taylor AL
Intern Med J; 2008 Oct; 38(10):781-9. PubMed ID: 18422565
[TBL] [Abstract][Full Text] [Related]
11. The Safety Profile of Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis: Are TNF Inhibitors Safer Than We Thought?
Wroński J; Fiedor P
J Clin Pharmacol; 2019 Apr; 59(4):445-462. PubMed ID: 30476367
[TBL] [Abstract][Full Text] [Related]
12. Golimumab: a new anti-TNF-alpha agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Voulgari PV
Expert Rev Clin Immunol; 2010 Sep; 6(5):721-33. PubMed ID: 20828280
[TBL] [Abstract][Full Text] [Related]
13. Sensorineural hearing loss in ankylosing spondylitis treated with TNF blockers.
Savastano M; Marioni G; Giacomelli L; Ramonda R; Ferraro SM; Punzi L
B-ENT; 2010; 6(3):183-8. PubMed ID: 21090160
[TBL] [Abstract][Full Text] [Related]
14. Etanercept: in ankylosing spondylitis.
McCormack PL; Wellington K
BioDrugs; 2004; 18(3):199-205; discussion 206. PubMed ID: 15161337
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab for the treatment of ankylosing spondylitis.
Sieper J; Rudwaleit M; Braun J
Expert Opin Pharmacother; 2007 Apr; 8(6):831-8. PubMed ID: 17425478
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor as a therapeutic target of rheumatologic disease.
Ackermann C; Kavanaugh A
Expert Opin Ther Targets; 2007 Nov; 11(11):1369-84. PubMed ID: 18028004
[TBL] [Abstract][Full Text] [Related]
17. New therapeutic approaches for spondyloarthritis.
Manadan AM; James N; Block JA
Curr Opin Rheumatol; 2007 May; 19(3):259-64. PubMed ID: 17414952
[TBL] [Abstract][Full Text] [Related]
18. Developments and current pharmacotherapeutic recommendations for ankylosing spondylitis.
Zochling J; Braun J
Expert Opin Pharmacother; 2006 May; 7(7):869-83. PubMed ID: 16634710
[TBL] [Abstract][Full Text] [Related]
19. Towards the next generation of anti-TNF drugs.
Sfikakis PP; Tsokos GC
Clin Immunol; 2011 Dec; 141(3):231-5. PubMed ID: 22004846
[TBL] [Abstract][Full Text] [Related]
20. Anti-TNF-alpha therapy in ankylosing spondylitis.
Wendling D; Toussirot E
Expert Opin Pharmacother; 2004 Jul; 5(7):1497-507. PubMed ID: 15212600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
